Compare Revvity Inc (RVTY) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while State Street SPDR S&P Biotech ETF trades at $154.5. The key difference: Revvity Inc pays a 0.26% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| RVTY | XBI | |
|---|---|---|
Market Cap | $11.87B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $117.75 | $164.28 |
52-Week Low | $82.26 | $85.16 |
Enterprise Value | $14.36B | — |
Dividend Yield | 0.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
